āĻšā§āĻŽEVGN âĸ NASDAQ
add
Evogene Ltd
⧧.⧍⧝$
āĻāĻŖā§āĻāĻž āĻĒāϰā§:(⧧⧍.ā§Ēā§Ļ%)+ā§Ļ.ā§§ā§Ŧ
ā§§.ā§Ēā§Ģ$
āĻŦāύā§āϧ āĻāĻā§: ā§§ā§Ē āĻ
āĻā§āĻā§, ā§Ģ:ā§¨ā§Š:ā§Ļā§§ PM GMT -ā§Ē · USD · NASDAQ · āĻĄāĻŋāϏāĻā§āϞā§āĻŽāĻžāϰ
āϏā§āĻāĻāĻŽāĻžāϰā§āĻāĻŋāύ āϝā§āĻā§āϤāϰāĻžāώā§āĻā§āϰ-āĻ āϤāĻžāϞāĻŋāĻāĻžāĻā§āĻā§āϤ āϏāĻŋāĻāĻŋāĻāϰāĻŋāĻāĻŋ
āĻāĻžāϞ āĻļā§āώ āϝ⧠āĻĻāĻžāĻŽā§ āĻāĻŋāϞ
ā§§.ā§¨ā§Ž$
āϏāĻžāϰāĻž āĻĻāĻŋāύā§āϰ āĻā§āϰā§āĻĄāĻŋāĻā§ā§ āϏā§āĻāĻā§āϰ āĻĻāĻžāĻŽā§āϰ āĻāĻ āĻž āύāĻžāĻŽāĻžāϰ āϰā§āĻā§āĻ
ā§§.⧍ā§Ē$ - ā§§.ā§Šā§Ģ$
āϏāĻžāϰāĻž āĻŦāĻāϰā§āϰ āϰā§āĻā§āĻ
ā§Ļ.⧝ā§Ģ$ - ⧍.ā§Žā§$
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
ā§§.ā§§ā§¨Â āĻā§ USD
āĻāĻĄāĻŧ āĻāϞāĻŋāĻāĻŽ
⧝⧍.ā§Ģā§Ģ āĻšāĻž
P/E āĻ
āύā§āĻĒāĻžāϤ
-
āϞāĻā§āϝāĻžāĻāĻļ āĻĒā§āϰāĻĻāĻžāύ
-
āĻĒā§āϰāĻžāĻāĻŽāĻžāϰāĻŋ āĻāĻā§āϏāĻā§āĻā§āĻ
NASDAQ
āĻŦāĻžāĻāĻžāϰ āϏāĻāĻŦāĻžāĻĻ
āĻĢāĻžāĻāύāĻžāύā§āϏāĻŋā§āĻžāϞ āĻĒāĻžāϰāĻĢāϰā§āĻŽā§āϝāĻžāύā§āϏ
āĻā§ā§āϰ āϏā§āĻā§āĻāĻŽā§āύā§āĻ
āĻāĻĒāĻžāϰā§āĻāύ
āύā§āĻ āĻāύāĻāĻžāĻŽ
(USD) | āĻā§āύ ⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻāĻĒāĻžāϰā§āĻāύ | ā§Ž.ā§Žā§Ē āϞāĻž | -ā§Š.ā§¨ā§Ž% |
āĻŦā§āϝāĻŦāϏāĻž āĻāĻžāϞāĻžāύā§āϰ āĻāϰāĻ | ā§Šā§Ž.ā§§ā§¯Â āϞāĻž | â |
āύā§āĻ āĻāύāĻāĻžāĻŽ | -ā§Ēā§Ē.ā§Ŧā§¨Â āϞāĻž | â |
āύā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ āĻŽāĻžāϰā§āĻāĻŋāύ | -ā§Ģā§Ļā§Ē.ā§ā§Ģ | â |
āĻļā§ā§āĻžāϰ āĻĒā§āϰāϤāĻŋ āĻāĻĒāĻžāϰā§āĻāύ | -ā§Ļ.ā§Ģā§Ļ | ā§Ģ⧍.ā§Žā§Š% |
EBITDA | -⧍ā§.ā§Žā§§Â āϞāĻž | â |
āĻĒā§āϰāϝā§āĻā§āϝ āĻā§āϝāĻžāĻā§āϏā§āϰ āĻšāĻžāϰ | -ā§Ļ.ā§Ļ⧍% | â |
āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļāĻŋāĻ
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
(USD) | āĻā§āύ ⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻā§āϝāĻžāĻļ āĻ āĻāĻŽ āϏāĻŽā§ā§āϰ āĻŦāĻŋāύāĻŋā§ā§āĻ | ā§§.ā§§ā§Â āĻā§ | -ā§Ēā§Ē.ā§Ļā§Ž% |
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | ā§Š.ā§Šā§¯Â āĻā§ | -ā§§ā§.⧧⧝% |
āĻŽā§āĻ āĻĻāĻžā§ | ⧍.ā§§ā§Ŧ āĻā§ | ⧍.ā§Ē⧝% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§§.⧍ā§Ē āĻā§ | â |
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ | ā§Žā§.ā§§ā§Ē āϞāĻž | â |
āĻĒā§āϰāĻžāĻāϏ āĻā§ āĻŦā§āĻ āϰā§āĻļāĻŋāĻ | -ā§Š.⧧⧍ | â |
āϏāĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | -⧍⧍.ā§Ģā§Ļ% | â |
āĻŽā§āϞāϧāύ āĻĨā§āĻā§ āĻā§ | -ā§Ģā§§.ā§§ā§Ģ% | â |
āĻā§āϝāĻžāĻļ āĻĢā§āϞā§
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ
(USD) | āĻā§āύ ⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āύā§āĻ āĻāύāĻāĻžāĻŽ | -ā§Ēā§Ē.ā§Ŧā§¨Â āϞāĻž | â |
āĻ
āĻĒāĻžāϰā§āĻļāύ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āϝāĻžāĻļ | -ā§¨ā§Š.ā§Ļā§§Â āϞāĻž | â |
āĻŦāĻŋāύāĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -⧝.ā§Žā§¯Â āϞāĻž | â |
āĻĢāĻžāĻāύā§āϝāĻžāύā§āϏāĻŋāĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | ā§Ēā§§.ā§Ēā§¯Â āϞāĻž | â |
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ | ā§Ž.ā§Šā§Ē āϞāĻž | â |
āĻĢā§āϰāĻŋ āĻā§āϝāĻžāĻļ āĻĢā§āϞ⧠| -ā§§.ā§¨ā§¨Â āĻā§ | â |
āϏāĻŽā§āĻĒāϰā§āĻā§
Evogene is a computational biology company based in Israel, specializing in predictive biology platforms that leverage artificial intelligence and machine learning for life-science product development. Evogene's platforms focus on designing novel microbes, small molecules, and genetic elements for use in pharmaceuticals, agriculture, and related industries. In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
āϏāĻŋāĻāĻ
āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ā§āĻā§
⧧⧝⧝⧝
āĻā§ā§āĻŦāϏāĻžāĻāĻ
āĻāϰā§āĻŽāĻāĻžāϰā§
ā§§ā§§ā§